[Arsenic poisoning in animals]. 1976

K P Balatskiĭ

UI MeSH Term Description Entries
D008297 Male Males
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002418 Cattle Diseases Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus. Bovine Diseases,Bovine Disease,Cattle Disease,Disease, Bovine,Disease, Cattle,Diseases, Bovine,Diseases, Cattle
D004112 Dimercaprol An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning. 2,3-Dimercaptopropanol,2,3-Dithiopropan-1-o1,B.A.L.,BAL in Oil,British Anti-Lewisite,British Anti-Lewisite Agent,Cadmium 2,3-Dimercaptopropanol,Dicaptol,2,3 Dimercaptopropanol,2,3 Dithiopropan 1 o1,2,3-Dimercaptopropanol, Cadmium,Anti-Lewisite Agent, British,Anti-Lewisite, British,British Anti Lewisite,British Anti Lewisite Agent,Cadmium 2,3 Dimercaptopropanol,Oil, BAL in,in Oil, BAL
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000931 Antidotes Agents counteracting or neutralizing the action of POISONS. Antidote,Theriacs
D014494 Unithiol A chelating agent used as an antidote to heavy metal poisoning. 2,3-Dimercapto-1-propanesulfonic Acid,2,3-Dimercaptopropane 1-Sodium Sulfonate,2,3-Dimercaptopropane-1-sulfonate Sodium,2,3-Dimercaptopropanesulfonic Acid,DMPS,DMPS-Heyl,Dimaval,Mercuval,Sodium 2,3-Dimercaptopropane Sulfonate,Sodium 2,3-Dithiopropanesulfate,Unitiol,1-Sodium Sulfonate, 2,3-Dimercaptopropane,2,3 Dimercapto 1 propanesulfonic Acid,2,3 Dimercaptopropane 1 Sodium Sulfonate,2,3 Dimercaptopropane 1 sulfonate Sodium,2,3 Dimercaptopropanesulfonic Acid,2,3-Dimercaptopropane Sulfonate, Sodium,2,3-Dithiopropanesulfate, Sodium,DMPS Heyl
D020261 Arsenic Poisoning Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212) Arsenic Encephalopathy,Arsenic Induced Polyneuropathy,Arsenic Poisoning, Inorganic,Arsenic Poisoning, Nervous System,Arsenic Poisoning, Organic,Encephalopathy, Arsenic,Inorganic Arsenic Poisoning,Nervous System Poisoning, Arsenic,Nervous System, Organic Arsenic Poisoning,Neurotoxicity Syndrome, Arsenical,Organic Arsenic Poisoning, Nervous System,Poisoning, Arsenic, Nervous System,Polyneuropathy, Arsenic-Induced,Arsenic Encephalopathies,Arsenic Poisonings,Arsenic Poisonings, Inorganic,Arsenic Poisonings, Organic,Arsenic-Induced Polyneuropathies,Arsenic-Induced Polyneuropathy,Arsenical Neurotoxicity Syndrome,Arsenical Neurotoxicity Syndromes,Encephalopathies, Arsenic,Inorganic Arsenic Poisonings,Neurotoxicity Syndromes, Arsenical,Organic Arsenic Poisoning,Organic Arsenic Poisonings,Poisoning, Arsenic,Poisoning, Inorganic Arsenic,Poisoning, Organic Arsenic,Poisonings, Arsenic,Poisonings, Inorganic Arsenic,Poisonings, Organic Arsenic,Polyneuropathy, Arsenic Induced,Syndrome, Arsenical Neurotoxicity,Syndromes, Arsenical Neurotoxicity

Related Publications

K P Balatskiĭ
August 1977, Environmental health perspectives,
K P Balatskiĭ
January 1968, New Zealand veterinary journal,
K P Balatskiĭ
October 1982, The New England journal of medicine,
K P Balatskiĭ
July 2011, BioTechniques,
K P Balatskiĭ
September 1988, The Western journal of medicine,
K P Balatskiĭ
May 1982, Recenti progressi in medicina,
K P Balatskiĭ
February 1972, Harefuah,
K P Balatskiĭ
November 2004, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
K P Balatskiĭ
February 1980, Southern medical journal,
K P Balatskiĭ
January 1981, Southern medical journal,
Copied contents to your clipboard!